Innovation and science within reach — for research use only, not intended for human consumption.


Elor4lintid3 10mg

Investigational Amylin Receptor Agonist for Weight Management Research Eloralintide (LY3841136) is an investigational, long-acting injectable medication developed by Eli Lilly and Company and being studied for the treatment of obesity and related cardiometabolic conditions. It belongs to a class of compounds known as selective amylin receptor agonists and is designed for once-weekly administration. Amylin is a hormone naturally released after meals that contributes to appetite regulation and feelings of fullness. Eloralintide is designed to preferentially activate the amylin 1 receptor (AMY1R), with the aim of reducing appetite and food intake and supporting body-weight reduction. Eloralintide remains an investigational medicine and has not been established as an approved treatment for routine clinical use. Mechanism of Action Eloralintide is being investigated for its effects on amylin receptor signaling and the regulation of energy intake. Selective Amylin Receptor Activation: Eloralintide has demonstrated preferential activity at the amylin 1 receptor (AMY1R) in preclinical studies. This receptor selectivity distinguishes it from some other amylin receptor agonists under investigation. Appetite and Satiety Regulation: By activating amylin-related signaling pathways, eloralintide is designed to influence hunger, promote feelings of fullness, and reduce food intake. Body-Weight Regulation: Preclinical research indicates that eloralintide can reduce food intake and body weight, primarily through reductions in fat mass in animal models. Its effects in humans have been evaluated in clinical trials. Clinical Efficacy and Trial Results Eloralintide has completed Phase 1 and Phase 2 clinical studies and is being evaluated in Phase 3 trials. In a 48-week, randomized, placebo-controlled Phase 2 trial involving 263 adults with overweight or obesity and at least one weight-related complication, participants received different weekly doses of eloralintide or placebo. Clinical Measure Reported Findings Body-Weight Reduction Mean body-weight changes at week 48 ranged from approximately 9% to 20% reduction across the eloralintide treatment groups, depending on the dose and dosing regimen. Placebo Group Mean body-weight change was approximately −0.4% at week 48. Most Common Adverse Events Nausea and fatigue were among the most frequently reported adverse events. Their frequency varied across treatment groups and doses. These results were published in The Lancet in 2025. They represent findings from a Phase 2 trial and do not establish the medicine's long-term effectiveness or safety across all populations. Potential Therapeutic Applications Obesity Research: Eloralintide is being studied as a potential pharmacological treatment for obesity and overweight in people with weight-related complications. Appetite and Satiety Research: Its selective amylin receptor activity provides a basis for investigating the hormonal regulation of appetite and food intake. Obesity-Related Conditions: Clinical development includes the investigation of conditions associated with obesity, including obstructive sleep apnea and knee osteoarthritis pain. Combination Therapy Research: Eloralintide is also being studied in combination with tirzepatide, a dual GIP/GLP-1 receptor agonist. The combination, referred to as EloraTZP, is being evaluated separately and should not be confused with eloralintide monotherapy. These are investigational applications. Eloralintide is not an established treatment for any of these conditions. Current Development Status and Safety As of October 2026, eloralintide remains an investigational medicine that has not been approved for routine clinical use . Eli Lilly is conducting Phase 3 clinical trials to evaluate its efficacy and safety in people with obesity, with or without related conditions. In the Phase 2 trial, commonly reported adverse events included nausea and fatigue. The frequency of these effects varied by dose. The available findings do not establish the full long-term safety profile, and additional clinical data are required. Eloralintide should not be presented as an approved weight-loss medicine or as a substitute for individualized medical assessment and evidence-based treatment. Investigational compound — Clinical research findings are intended to support scientific evaluation and do not establish approval or suitability for human use outside authorized clinical trials.

235.00 € 300.00 €

Ret4trutide 20Mg

Ret4trutide is a novel investigational therapeutic agent that functions as a triple receptor agonist targeting the GLP-1, GIP, and glucagon receptors for the management of obesity and type 2 diabetes mellitus. Clinical trial data indicate mean body weight reductions exceeding 24% over a 48-week period , demonstrating superior efficacy compared to currently available pharmacological interventions. Ret4trutide is currently undergoing late-stage clinical development (Phase III trials) , with additional metabolic effects and therapeutic applications under active investigation, particularly in the context of metabolic optimization and energy homeostasis. For research use only – Intended exclusively for qualified professionals conducting scientific and clinical research.

75.00 € 120.00 €

Tirz3patid4 20Mg

Tirz3patid3 , marketed as M0unjar0 , is a once-weekly injectable medication approved in Portugal (late 2024) for the treatment of type 2 diabetes mellitus and obesity/overweight . It functions as a dual agonist of the GIP and GLP-1 receptors , enhancing satiety and reducing appetite, which results in clinically significant weight loss . For research use only – Intended exclusively for qualified professionals conducting scientific research.

70.00 € 100.00 €

L-Carnitina 1200mg/ML 10ML

L-Carnitine is an amino acid-derived compound whose primary function is to transport fatty acids into the mitochondria—the energy-producing centers of cells—where they are converted into fuel. Although it is highly popular in the fitness industry, its effectiveness is a combination of scientifically proven benefits and common misconceptions. Key Proven Benefits Physical Performance and Recovery Reduced fatigue: Helps decrease muscle fatigue and lactate accumulation during prolonged exercise. Post-workout recovery: Reduces tissue damage and muscle soreness following intense training sessions, while supporting oxygen delivery to the muscles. Glycogen preservation: Helps conserve muscle glycogen stores and reduces the reliance on amino acids as an energy source. Cognitive Health and Nervous System Support Focus and memory: In its Acetyl-L-Carnitine (ALCAR) form, it readily crosses the blood-brain barrier, helping to support and protect brain function. Prevention of cognitive decline: Research suggests potential benefits in improving cognitive performance and reducing mental fatigue in older adults. Cardiovascular and General Health Cardiac support: Assists the heart's energy metabolism, helping to alleviate symptoms of angina and reduce post-heart attack mortality. Antioxidant activity: Helps lower inflammatory markers and combats free radicals within the body. The Rapid Weight Loss Myth Many people use L-Carnitine as a "miracle fat burner." However, scientific evidence provides a more accurate picture: It does not work without exercise: L-Carnitine only optimizes fat transport. Without a calorie deficit and physical activity that requires energy expenditure, supplementation is unlikely to produce meaningful results. Mixed scientific evidence: Reviews of clinical studies indicate that weight loss from L-Carnitine supplementation alone is generally modest and varies considerably between individuals. For research purposes only – Intended for qualified professionals conducting scientific research.

40.00 €

Tirz3patid4 40Mg

Tirz3patid3 , marketed as M0unjar0 , is a once-weekly injectable medication approved in Portugal (late 2024) for the treatment of type 2 diabetes mellitus and obesity/overweight . It functions as a dual agonist of the GIP and GLP-1 receptors , enhancing satiety and reducing appetite, which results in clinically significant weight loss . For research use only – Intended exclusively for qualified professionals conducting scientific research.

100.00 € 160.00 €

Ret4trutide 100Mg

Ret4trutide  is a novel investigational therapeutic agent that functions as a triple receptor agonist targeting the GLP-1, GIP, and glucagon receptors for the management of obesity and type 2 diabetes mellitus. Clinical trial data indicate mean body weight reductions exceeding 24% over a 48-week period, demonstrating superior efficacy compared to currently available pharmacological interventions. Ret4trutide is currently undergoing late-stage clinical development (Phase III trials), with additional metabolic effects and therapeutic applications under active investigation, particularly in the context of metabolic optimization and energy homeostasis. For research use only – Intended exclusively for qualified professionals conducting scientific and clinical research.

290.00 € 400.00 €

Tirz3patid4 100Mg

Tirz3patid3 , marketed as M0unjar0 , is a once-weekly injectable medication approved in Portugal (late 2024) for the treatment of type 2 diabetes mellitus and obesity/overweight . It functions as a dual agonist of the GIP and GLP-1 receptors , enhancing satiety and reducing appetite, which results in clinically significant weight loss . For research use only – Intended exclusively for qualified professionals conducting scientific research.

200.00 € 300.00 €

DSIP 10mg

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide composed of nine amino acids , known for its involvement in the regulation of deep, slow-wave (delta) sleep . Originally isolated in rabbits in the 1970s, DSIP has been studied for its effects on the central nervous system , particularly in relation to sleep–wake regulation, stress adaptation, and neurophysiological recovery . Key Characteristics and Areas of Investigation Sleep Regulation DSIP has been investigated for its potential role in promoting slow-wave (delta) sleep and supporting restorative sleep architecture , without producing the pronounced sedative effects typically associated with conventional hypnotic agents. Mechanism of Action Experimental research suggests that DSIP interacts with the central nervous system , influencing neurotransmitter and neuroendocrine signaling pathways involved in sleep regulation. Studies indicate that DSIP is capable of crossing the blood–brain barrier , enabling central activity. Stress Modulation Preclinical studies have explored DSIP's potential to modulate stress-response pathways , including effects on hypothalamic–pituitary–adrenal (HPA) axis activity and cortisol regulation, contributing to improved stress adaptation. Additional Research Areas DSIP has also been investigated in experimental contexts for: Neuroprotective effects Modulation of withdrawal-related symptoms in substance dependence models Support of daytime cognitive alertness following improved sleep quality Research Context and Regulatory Status DSIP used in research settings is synthetically produced and remains primarily a subject of laboratory and experimental investigation . It is not approved by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), or national regulatory authorities for general clinical use in humans. The pharmacokinetics, long-term safety profile, and clinical efficacy of DSIP in humans have not been established through large-scale controlled clinical trials. ⚠️ DSIP is considered a sleep-regulating neuropeptide rather than a sedative agent , with research focusing on its influence on sleep pressure and circadian neurobiology rather than direct hypnotic effects. For research use only – Intended exclusively for qualified professionals conducting scientific research.

60.00 €

TB-500 5Mg

TB-500 is a synthetic peptide analog of thymosin beta-4 , a naturally occurring protein involved in tissue regeneration, wound healing, and modulation of inflammatory processes . Thymosin beta-4 is endogenously present at elevated concentrations in injured tissues, where it plays a role in cellular repair mechanisms. What It Is and How It Works Composition and Origin: TB-500 is a synthetic fragment derived from the naturally occurring protein thymosin beta-4 , which is associated with tissue repair and cytoskeletal regulation. Mechanism of Action: In experimental models, TB-500 has been shown to promote cell migration and proliferation , angiogenesis (formation of new blood vessels) , and extracellular matrix organization , all of which are critical processes in tissue repair and regeneration. Focus on Regeneration: Unlike growth hormone–based compounds, TB-500 does not directly act on the endocrine axis. Its activity is considered primarily structural and functional , supporting systemic tissue recovery without directly stimulating muscle hypertrophy or hormonal secretion. Potential Areas of Investigation Preclinical and experimental research has explored TB-500 in relation to: Tissue repair following muscle, tendon, ligament, and joint injury Modulation of inflammatory responses during healing Improvement of tissue flexibility and functional recovery in models of chronic injury Use, Regulatory Status, and Safety Considerations TB-500 is not approved as a medicinal product for human use by regulatory authorities, including Infarmed (Portugal) , Anvisa (Brazil) , or the U.S. Food and Drug Administration (FDA) . It is commonly classified as a research-use compound . The long-term safety profile in humans has not been established , due to the absence of large-scale, controlled clinical trials. Reported observations from non-clinical contexts cannot be considered evidence of safety or efficacy. TB-500 is also listed as a prohibited substance in competitive sports and is included on anti-doping prohibited lists . For research use only – Intended exclusively for qualified professionals conducting scientific research.

40.00 €

PT-141 10mg

PT-141 (also known as Bremelanotide) is a synthetic peptide investigated for the treatment of sexual dysfunction , acting centrally on the brain to enhance sexual desire and arousal . It has been approved by the U.S. Food and Drug Administration (FDA) under the trade name Vyleesi® for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women . Mechanism of Action Central Nervous System Activity Unlike traditional erectile dysfunction medications (e.g., sildenafil), which primarily act on the vascular system to increase peripheral blood flow, PT-141 exerts its effects at the level of the central nervous system (CNS) . Melanocortin Receptors PT-141 functions as an agonist of melanocortin receptors , specifically MC3R and MC4R , which are highly expressed in the hypothalamus , a key brain region involved in sexual behavior and motivation. Neurotransmitter Modulation Activation of these receptors promotes the release of neurotransmitters such as dopamine —associated with reward, motivation, and desire—and oxytocin , which plays a central role in sexual arousal, bonding, and emotional response . Sexual Desire and Physiological Response Through its central mechanism, PT-141 enhances sexual desire , which may secondarily improve physiological sexual responses , including increased genital blood flow and, in men, improved erectile response. For research use only – Intended exclusively for qualified professionals conducting scientific research.

40.00 €

HC 24iu (GH)

Growth Hormone (GH) – Clinical and Regulatory Framework in the European Union Human Growth Hormone (GH) is used within the European Union as part of recombinant GH replacement therapies , strictly under medical prescription and for well-defined clinical indications . In Portugal and other EU Member States, GH is approved for use in children with medically diagnosed growth disorders and in adults with confirmed growth hormone deficiency , in accordance with guidance from the European Medicines Agency (EMA) and national health authorities. GH is administered via daily subcutaneous injections and exerts its effects by stimulating linear bone growth , metabolic regulation , and hepatic production of insulin-like growth factor 1 (IGF-1) . Key Regulatory Considerations Approved indications: Treatment of pediatric growth disorders and adult GH deficiency following comprehensive clinical evaluation. Treatment regimen: Daily subcutaneous administration under specialist medical supervision. Physiological effects: When used within approved indications, GH therapy is associated with improvements in body composition , metabolic function , and quality of life . Risks and warnings: Use outside approved indications or without medical supervision may result in serious adverse effects , including acromegaly, fluid retention, joint pain, and metabolic disturbances. ⚠️ GH is not approved for anti-aging, cosmetic, or performance-enhancement purposes. For research use only – Information intended for qualified professionals conducting scientific research.

65.00 €

TB-500 10Mg

TB-500 is a synthetic peptide analog of thymosin beta-4 , a naturally occurring protein involved in tissue regeneration, wound healing, and modulation of inflammatory processes . Thymosin beta-4 is endogenously present at elevated concentrations in injured tissues, where it plays a role in cellular repair mechanisms. What It Is and How It Works Composition and Origin: TB-500 is a synthetic fragment derived from the naturally occurring protein thymosin beta-4 , which is associated with tissue repair and cytoskeletal regulation. Mechanism of Action: In experimental models, TB-500 has been shown to promote cell migration and proliferation , angiogenesis (formation of new blood vessels) , and extracellular matrix organization , all of which are critical processes in tissue repair and regeneration. Focus on Regeneration: Unlike growth hormone–based compounds, TB-500 does not directly act on the endocrine axis. Its activity is considered primarily structural and functional , supporting systemic tissue recovery without directly stimulating muscle hypertrophy or hormonal secretion. Potential Areas of Investigation Preclinical and experimental research has explored TB-500 in relation to: Tissue repair following muscle, tendon, ligament, and joint injury Modulation of inflammatory responses during healing Improvement of tissue flexibility and functional recovery in models of chronic injury Use, Regulatory Status, and Safety Considerations TB-500 is not approved as a medicinal product for human use by regulatory authorities, including Infarmed (Portugal) , Anvisa (Brazil) , or the U.S. Food and Drug Administration (FDA) . It is commonly classified as a research-use compound . The long-term safety profile in humans has not been established , due to the absence of large-scale, controlled clinical trials. Reported observations from non-clinical contexts cannot be considered evidence of safety or efficacy. TB-500 is also listed as a prohibited substance in competitive sports and is included on anti-doping prohibited lists . For research use only – Intended exclusively for qualified professionals conducting scientific research.

70.00 €

Sermorelin 10Mg

Sermorelin is a synthetic peptide and an analog of growth hormone–releasing hormone (GHRH) that stimulates the pituitary gland to increase endogenous human growth hormone (hGH) secretion . In research settings, sermorelin has been investigated for its effects on physiological GH pulsatility , with exploratory interest in areas such as sleep regulation, energy metabolism, body composition, and age-related endocrine changes . Administered via subcutaneous injection in experimental protocols, sermorelin is studied as a potential alternative approach to direct GH administration, due to its mechanism of promoting natural GH release rather than exogenous hormone replacement. Observational research typically evaluates outcomes over periods ranging from 30 to 90 days , depending on study design. For research use only – Intended exclusively for qualified professionals conducting scientific research.

60.00 €

Melanotan II 10Mg

Melanotan II (MTII) is a synthetic peptide analog of the endogenous hormone α-melanocyte-stimulating hormone (α-MSH) , originally developed to stimulate cutaneous melanogenesis by increasing melanin production. In experimental contexts, MTII has also been observed to influence sexual arousal pathways , including effects on libido and erectile function, via central melanocortin receptor activation. However, cosmetic or non-clinical use of Melanotan II is not approved and has been associated with significant health risks , including nausea, hyperpigmentation and nevus formation, potential increased risk of melanoma, cardiovascular events, and cerebrovascular complications . Due to these concerns, MTII remains restricted to experimental investigation. For research use only – Intended exclusively for qualified professionals conducting scientific research.

30.00 €

HCG 10000iu

Human chorionic gonadotropin (hCG) is a glycoprotein peptide hormone produced primarily during pregnancy to maintain the corpus luteum . In medical and research contexts, hCG has been used to treat infertility , induce ovulation in women , and stimulate testosterone production in hypogonadal men , frequently acting as a functional analog of luteinizing hormone (LH) . Recent research has also explored potential anti-inflammatory properties of hCG, with studies suggesting that the β-subunit of hCG may contribute to the modulation and control of inflammatory responses. For research use only – Intended exclusively for qualified professionals conducting scientific research.

75.00 €

Kisspeptin 10mg

Kisspeptin is a critical peptide hormone in human reproduction, functioning as a master regulator of the reproductive axis by stimulating gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus. This, in turn, triggers the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) , which are essential for sex hormone production, pubertal onset, and fertility . Originally identified as a metastasis suppressor , kisspeptin is now known to play broader roles in mood regulation, behavior, and potentially metabolic processes . Its actions are mediated through the GPR54 (KISS1R) receptor within the KNDy neuronal network , and it is actively investigated for therapeutic applications in fertility-related disorders . For research use only – Intended exclusively for qualified professionals conducting scientific research.

45.00 €

Thymosin Alpha1 10Mg

Thymosin Alpha-1 (Tα1) is a naturally occurring 28–amino acid peptide derived from the thymus gland , playing a critical role in the regulation, enhancement, and restoration of immune function . It promotes the differentiation and maturation of T lymphocytes , as well as the activation of natural killer (NK) cells and dendritic cells , thereby supporting both innate and adaptive immune responses. Thymosin Alpha-1 has been extensively studied for its potential to strengthen immune defense mechanisms in the context of infectious diseases, cancer, and autoimmune disorders . For research use only – Intended exclusively for qualified professionals conducting scientific research.

75.00 €

Tesamorelin 10Mg

Tesamorelin is a synthetic peptide and an analog of growth hormone–releasing hormone (GHRH) , developed to reduce excess visceral (abdominal) adipose tissue in patients with HIV-associated lipodystrophy . Approved by the U.S. Food and Drug Administration (FDA) in 2010 , tesamorelin acts by stimulating the pituitary gland to release growth hormone (GH) in a physiological manner , thereby contributing to fat redistribution and improvement of lipid profiles . For research use only – Intended exclusively for qualified professionals conducting scientific research.

85.00 €

SS-31 50Mg

SS-31 (Elamipretide) is a cutting-edge, mitochondria-targeted peptide designed to directly protect and restore mitochondrial energy function (ATP production) . By binding to cardiolipin within the inner mitochondrial membrane , SS-31 stabilizes mitochondrial structure, reduces oxidative stress , and mitigates mechanisms associated with cellular aging . It is under active investigation for potential applications in degenerative diseases, mitochondrial myopathies, and longevity research . For research use only – Intended exclusively for qualified professionals conducting scientific research.

135.00 €

Tirz3patid4 50Mg

Tirz3patid3 , marketed as M0unjar0 , is a once-weekly injectable medication approved in Portugal (late 2024) for the treatment of type 2 diabetes mellitus and obesity/overweight . It functions as a dual agonist of the GIP and GLP-1 receptors , enhancing satiety and reducing appetite, which results in clinically significant weight loss . For research use only – Intended exclusively for qualified professionals conducting scientific research. Lab Test

120.00 € 200.00 €

NAD + 1000Mg

NAD⁺ (nicotinamide adenine dinucleotide) is an essential coenzyme present in all living cells, playing a critical role in cellular energy production (ATP synthesis), DNA repair, and metabolic function . As the biologically active form of vitamin B3, NAD⁺ levels decline with aging, which has driven scientific interest in NAD⁺ precursors such as NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) for their potential roles in enhancing cellular energy metabolism and supporting cellular longevity. For research use only – Intended exclusively for qualified professionals conducting scientific research.

70.00 €

5-Amino-1MQ 50Mg

Experimental NNMT Inhibitor for Metabolic Research 5-Amino-1MQ is an experimental small molecule investigated for its ability to inhibit nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolism. Unlike peptides, 5-Amino-1MQ is a synthetic chemical compound studied primarily in laboratory and animal models for its potential effects on fat metabolism, energy regulation, and obesity-related metabolic dysfunction. NNMT participates in the metabolism of nicotinamide and S-adenosylmethionine (SAM), two molecules involved in important cellular biochemical pathways. By inhibiting this enzyme, 5-Amino-1MQ is being investigated as a potential tool for understanding metabolic regulation and adipose tissue biology. The compound remains experimental, and its efficacy and safety have not been established in human clinical trials. Proposed Mechanism of Action 5-Amino-1MQ is being studied for its ability to inhibit NNMT and influence related metabolic pathways. NNMT Inhibition: 5-Amino-1MQ inhibits nicotinamide N-methyltransferase, an enzyme involved in the metabolism of nicotinamide and the methyl donor S-adenosylmethionine. Cellular Metabolism: Experimental studies suggest that NNMT inhibition can alter intracellular levels of metabolites associated with NAD+ metabolism and cellular methylation processes. Adipose Tissue Research: In cell and animal models, NNMT inhibition has been associated with changes in fat accumulation, adipocyte biology, and metabolic parameters. The extent to which these effects translate to humans is unknown. Research Findings and Available Evidence Research on 5-Amino-1MQ is predominantly preclinical. Laboratory Studies: Cell-based experiments have demonstrated NNMT inhibition and changes in metabolic pathways associated with nicotinamide metabolism and fat-cell biology. Animal Studies: Studies in mice with diet-induced obesity have reported reduced body-weight and fat-mass gains, alongside improvements in selected measures of glucose regulation, insulin sensitivity, and liver fat accumulation. Metabolic Research: Additional experimental work has investigated the relationship between NNMT activity, cellular metabolism, and obesity-related metabolic dysfunction. These findings are limited to experimental models. They do not establish that 5-Amino-1MQ causes weight loss, improves metabolic health, or treats obesity in humans. Potential Research Applications Adipose Tissue Biology: Investigating the role of NNMT in fat-cell metabolism and lipid accumulation. Energy Metabolism: Studying the relationship between NNMT activity, NAD+ metabolism, and cellular energy pathways. Obesity Research: Exploring potential molecular targets involved in obesity-related metabolic dysfunction. Glucose and Liver Metabolism: Investigating metabolic changes observed in preclinical models, including glucose regulation and hepatic fat accumulation. These are research areas rather than established therapeutic indications. 5-Amino-1MQ has not been demonstrated to be an effective treatment for obesity, diabetes, fatty liver disease, or other metabolic disorders in humans. Development Status and Safety 5-Amino-1MQ remains an experimental research compound and is not an approved medicine for routine clinical use . The published evidence identified to date is predominantly based on laboratory experiments and animal studies, with no established human clinical trial evidence demonstrating its safety or efficacy. Human pharmacokinetics, optimal dosing, absorption, metabolism, potential drug interactions, and long-term safety remain insufficiently characterized. Findings from animal studies cannot reliably predict the effects or risks of the compound in humans. 5-Amino-1MQ should not be presented as a clinically proven fat-loss compound, a metabolism-enhancing treatment, or an established alternative to approved obesity therapies. For research use only — Intended exclusively for qualified professionals conducting scientific research. Not intended for human or veterinary use, self-administration, or the diagnosis, treatment, cure, or prevention of any disease. LAB TEST

60.00 €

BPC157 10Mg

BPC-157 (Body Protection Compound) is a synthetic peptide derived from a sequence found in human gastric juice, studied for its pronounced regenerative effects in tendons, muscles, ligaments, and the gastrointestinal tract . Preclinical research has investigated its role in tissue repair, cytoprotection, and modulation of inflammatory pathways , as well as its potential to support healing processes following tissue injury. Current research focuses on its anti-inflammatory properties, wound-healing mechanisms, and effects on tissue regeneration across various experimental models. For research use only – Intended exclusively for qualified professionals conducting scientific research. LAB TEST

30.00 € 35.00 €

Epithalon 50Mg

Epitalon (also known as Epithalon) is a synthetic tetrapeptide ( Ala–Glu–Asp–Gly ) developed to mimic the natural pineal gland extract epithalamin , which has been associated with potential anti-aging and longevity-related effects . Epitalon is reported to act by stimulating telomerase activity , thereby contributing to telomere length maintenance, reduction of oxidative stress, and regulation of melatonin secretion. Current research focuses primarily on its potential roles in lifespan extension, sleep regulation, and enhancement of cellular repair mechanisms . For research use only – Intended exclusively for qualified professionals conducting scientific research.

65.00 €

    Best Sellers

    High-Quality Peptides for Scientific Research

    PeptWorld is an online store specialized in peptides for scientific research, providing high-purity solutions for exclusive laboratory use. It works with carefully selected synthetic peptides, intended for researchers, scientific institutions, and biotechnology professionals.

    Peptides play a fundamental role in modern research and are widely used in the study of cellular processes, molecular interactions, and complex biochemical mechanisms. PeptWorld offers a diverse range of peptides developed to ensure consistency, reliability, and scientific traceability.

    Synthetic peptides for laboratory research

    The synthetic peptides are produced according to strict quality criteria, ensuring:

    • High purity

    • Molecular stability

    • Batch-to-batch reproducibility

    • Compliance with laboratory standards

    Each product is accompanied by clear technical information, allowing safe and controlled use in scientific research contexts.

    Exclusive use for scientific research

    All products sold by PeptWorld are intended exclusively for research and laboratory use.
    They are not medicines, are not intended for human consumption, and are not for therapeutic applications.

    Transparency and compliance with legal standards are part of the commitment to the scientific community.

    👉 Explore the selection of peptides for scientific research and find solutions suited to laboratory needs.